Quintiles has launched its Integrated Asset Development Plan (IADP) offering, a suite of services for development, regulatory strategy, market and patient access and commercial services to help facilitate the strategic planning process, data analytics and modeling.
 
“In today’s increasingly complex healthcare market, a successful asset must meet key value objectives and evidence needs for a variety of stakeholders, including patients, providers, regulators and payers,” said Rick Sax, M.D., senior vice president, Quintiles Advisory Services. “A successful asset development plan considers the dynamic requirements of stakeholders to enable better decisions during development. With IADP, we bring an objective view of commercial viability, a structured design process and robust technology to create an approach that helps our customers improve their probability of success.”
 
As part of the IADP offering, Quintiles advises on considerations for an asset’s value proposition, Target Product Profile (TPP), regulatory plan, and a Clinical Development Plan (CDP). The IADP also includes market access planning, evidence generation plan, commercial launch plan, lifecycle management and real-world evidence risk management plans.